Oncology Alliance: Apeiron, CCRI and SIOPEN join forces against neuroblastoma
27-Jun-2011 -
Apeiron Biologics AG (Apeiron) announced the conclusion of an agreement with the Children's Cancer Research Institute (CCRI) and the European Neuroblastoma Research Network (SIOPEN). Thereby, Apeiron obtains the rights to further develop, file for regulatory approval and market the antibody ...
cancer
monoclonal antibodies
neuroblastoma